Connect
MJA
MJA

Letters

Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)?

Kirsty L Buising, Karin A Thursky, James F Black and Graham V Brown

Med J Aust 2004; 181 (9): 515-516

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Lloyd N Sansom

Med J Aust 2004; 181 (8): 457-458

Thyroid testing 10 years on

Richard X Davey

Med J Aust 2004; 181 (8): 462-464

Multicentre research: negotiating the ethics approval obstacle course

David J Maxwell and Karen I Kaye

Med J Aust 2004; 181 (8): 459-461

The Australian Government’s Review of Positron Emission Tomography: evidence-based policy decision-making in action

Nat Lenzo

Med J Aust 2004; 181 (9): 516-517

The medical profession and the pharmaceutical industry: when will we open our eyes?

Tim Woodruff

Med J Aust 2004; 181 (8): 458-459

Thyroid testing 10 years on

Jan R Stockigt

Med J Aust 2004; 181 (8): 462-464

Multicentre research: negotiating the ethics approval obstacle course

Martin B Van Der Weyden

Med J Aust 2004; 181 (8): 459-461

The Australian Government’s Review of Positron Emission Tomography: evidence-based policy decision-making in action

Robert E Ware, Hilton W Francis and Kenneth E Read

Med J Aust 2004; 181 (9): 516-517

The medical profession and the pharmaceutical industry: when will we open our eyes?

Linda V Graudins

Med J Aust 2004; 181 (8): 458-459

Preventing intrathecal administration of vincristine

Peter J Gilbar and Christine V Carrington

Med J Aust 2004; 181 (8): 464

Management of obesity

Gordon R W Davies

Med J Aust 2004; 181 (8): 461-462

The medical profession and the pharmaceutical industry: when will we open our eyes?

Scott Masters

Med J Aust 2004; 181 (8): 458-459

Management of obesity

Ray C McHenry, Richard W Gilhome and Chris Hensman

Med J Aust 2004; 181 (8): 461-462

The medical profession and the pharmaceutical industry: when will we open our eyes?

Rosanna Capolingua

Med J Aust 2004; 181 (8): 458-459

Management of obesity

Huy A Tran

Med J Aust 2004; 181 (8): 461-462

Multicentre research: negotiating the ethics approval obstacle course

Hugh G Dickson

Med J Aust 2004; 181 (8): 459-461

Subsidised access to TNFα inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Christine Y Lu, Kenneth M Williams, Lyn March, James V Bertouch and Richard O Day

Med J Aust 2004; 181 (8): 457-458

Management of obesity

Joseph Proietto and Louise A Baur

Med J Aust 2004; 181 (8): 461-462

Multicentre research: negotiating the ethics approval obstacle course

Kerry J Breen

Med J Aust 2004; 181 (8): 459-461

New recommendation on Japanese encephalitis vaccination for travellers to Papua New Guinea

George Rubin and Jeanette Baird, on behalf of the Australian Technical Advisory Group on Immunisation (ATAGI)

Med J Aust 2004; 181 (5): 283

Epidemic of γ-hydroxybutyrate (GHB) ingestion

T C K Brown

Med J Aust 2004; 181 (6): 343

Screening sigmoidoscopy for colorectal cancer

Geoffrey M Forbes, Matthew J Zimmerman, Brendan J Collins and John T Edwards

Med J Aust 2004; 181 (6): 343-344

Self-inflicted superglue injuries

Tarney J Spencer and Ben Clark

Med J Aust 2004; 181 (6): 341-341

Revision of guidelines for the management of gestational diabetes mellitus

Jeremy J N Oats and H David McIntyre

Med J Aust 2004; 181 (6): 342